Cabaletta Bio (CABA) Stock Price
$1.1 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Cabaletta Bio, AI stock picks, stock alerts and much more.
CABA AI Stock Analysis
Financial Performance
Cabaletta Bio's financial performance has been weak with no reported revenue and a gross profit of $0. The company's operating income was negative at -$33M, which indicates that the company is not generating enough revenue to cover its operational costs. Furthermore, the EBITDA ratio being at zero suggests that the company is not earning before interest, taxes, depreciation and amortization.
Stock Price
The stock price of Cabaletta Bio is currently trading at $2.56, which represents an increase of 15.3% over the last month but a significant drop of -89.9% YoY. The RSI value stands at 59.09 indicating that it's neither oversold nor overbought. However, the stock is trading well below its 200-day moving average of $5.89 suggesting a bearish trend in the long term.
Alternative Data Signals
In terms of alternative data signals, there has been a substantial increase in web traffic and job postings for Cabaletta Bio which could indicate growth or expansion within the company. An estimated 100% positive business outlook from employees also suggests strong internal confidence about future prospects despite current financial challenges.
The social media presence on Twitter has seen a modest increase over last quarter.
Conclusion
In conclusion, while there are some positive signs such as increased web traffic and positive employee sentiment towards business outlook; weak financials including lack of revenues and profits along with declining year-over-year stock price make us bearish on Cabaletta Bio's stock performance.
Note: This AI Stock Analysis is based on data as of February 07. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Cabaletta Bio (CABA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cabaletta Bio (CABA), currently trading at $1.1, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About CABA
-
Cabaletta Bio, Inc.
-
Symbol
CABA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
55.8M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
CABA Alternative Data
Web Traffic
Cabaletta Bio receives an estimated 14192 monthly visitors to cabalettabio.com.
-
Web Traffic
14192
-
Change from Previous Month
23.3%
-
3 Month Change
28.7%
-
YoY Change
28.7%
News Mentions
Cabaletta Bio was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
100%
-
3 Month Change
0%
Reddit Mentions
Cabaletta Bio has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
LinkedIn Followers
13,641 are following Cabaletta Bio on LinkedIn, up by 2.3% over the last month.
-
LinkedIn Followers
13641
-
Daily Change
0%
-
1 Month Change
2.3%
-
3 Month Change
6.4%
Twitter Followers
Cabaletta Bio has 474 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.6% over the last month.
-
Twitter Followers
474
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
0.2%
-
YoY Change
0.2%
Job Postings
Cabaletta Bio currenly has an estimated 11 open job postings, up by 37.5% over the last month.
-
Job Postings
11
-
Daily Change
0%
-
1 Month Change
37.5%
-
3 Month Change
120%
-
YoY Change
120%
LinkedIn Employees
According to LinkedIn, Cabaletta Bio has 173 employees.
-
LinkedIn Employees
173
-
Daily Change
0.6%
-
1 Month Change
0%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Business Outlook
According to employee reviews, the business outlook among employees at Cabaletta Bio is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
CABA Financials
CABA Key Metrics
-
Total Revenue
$0
-
Net Income
-$30.6M
-
Earnings per Share
-$0.63
-
Free cash flow
-$20.6M
-
EBITDA
-$32.6M
-
EBITDA Ratio
0
-
Total Assets
$204.4M
CABA 2-year Revenue & Income
CABA 2-year Free Cash Flow
CABA Technicals
CABA SMA
CABA RSI
FAQ
What's the current price of Cabaletta Bio (CABA) Stock?
The price of an Cabaletta Bio (CABA) share is $1.1.
What's the market cap of Cabaletta Bio?
The current market cap of Cabaletta Bio is 55.8M.
Should I buy or sell CABA?
Cabaletta Bio exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Cabaletta Bio a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Cabaletta Bio stock. There are several bearish signals and market challenges that could negatively impact Cabaletta Bio's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Cabaletta Bio (CABA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Cabaletta Bio stock right now, as the outlook appears bearish.
What are some stocks similar to Cabaletta Bio (CABA) that investors often compare it to?
Cabaletta Bio (CABA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Cabaletta Bio's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cabaletta Bio's stock price to be around $0.993 in 2026. Starting from the current price of $1.1, this represents a 9.7% change in price, indicating a bearish outlook for the stock.
How to buy Cabaletta Bio (CABA) Stock?
Cabaletta Bio stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cabaletta Bio shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.